Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes.

Pujol-Moix N, Martinez-Perez A, Sabater-Lleal M, Llobet D, Vilalta N, Hamsten A, Souto JC, Soria JM.

Int J Mol Sci. 2019 Jun 30;20(13). pii: E3221. doi: 10.3390/ijms20133221.

2.

Short closure time values in PFA-100® are related to venous thrombotic risk. Results from the RETROVE Study.

Vázquez-Santiago M, Vilalta N, Cuevas B, Murillo J, Llobet D, Macho R, Pujol-Moix N, Carrasco M, Mateo J, Fontcuberta J, Soria JM, Souto JC.

Thromb Res. 2018 Sep;169:57-63. doi: 10.1016/j.thromres.2018.07.012. Epub 2018 Jul 11.

PMID:
30015229
3.

Platelet count and plateletcrit are associated with an increased risk of venous thrombosis in females. Results from the RETROVE study.

Vázquez-Santiago M, Vilalta N, Ziyatdinov A, Cuevas B, Macho R, Pujol-Moix N, Carrasco M, Mateo J, Fontcuberta J, Soria JM, Souto JC.

Thromb Res. 2017 Sep;157:162-164. doi: 10.1016/j.thromres.2017.07.022. Epub 2017 Jul 23. No abstract available.

PMID:
28759761
4.

Erytrocyte-related phenotypes and genetic susceptibility to thrombosis.

Remacha AF, Vilalta N, Sardà MP, Millón J, Pujol-Moix N, Ziyatdinov A, Fontcuberta J, Nomdedeu J, Soria JM, Souto JC.

Blood Cells Mol Dis. 2016 Jul;59:44-8. doi: 10.1016/j.bcmd.2016.04.006. Epub 2016 Apr 13. No abstract available.

PMID:
27282566
5.

Age and gender effects on 15 platelet phenotypes in a Spanish population.

Vázquez-Santiago M, Ziyatdinov A, Pujol-Moix N, Brunel H, Morera A, Soria JM, Souto JC.

Comput Biol Med. 2016 Feb 1;69:226-33. doi: 10.1016/j.compbiomed.2015.12.023. Epub 2016 Jan 1.

PMID:
26773944
6.

Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.

Verver EJ, Topsakal V, Kunst HP, Huygen PL, Heller PG, Pujol-Moix N, Savoia A, Benazzo M, Fierro T, Grolman W, Gresele P, Pecci A.

Ear Hear. 2016 Jan-Feb;37(1):112-20. doi: 10.1097/AUD.0000000000000198.

PMID:
26226608
7.

Genetic determinants of platelet large-cell ratio, immature platelet fraction, and other platelet-related phenotypes.

Pujol-Moix N, Vázquez-Santiago M, Morera A, Ziyatdinov A, Remacha A, Nomdedeu JF, Fontcuberta J, Soria JM, Souto JC.

Thromb Res. 2015 Aug;136(2):361-6. doi: 10.1016/j.thromres.2015.06.016. Epub 2015 Jun 17.

PMID:
26148565
8.

Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders.

Civaschi E, Klersy C, Melazzini F, Pujol-Moix N, Santoro C, Cattaneo M, Lavenu-Bombled C, Bury L, Minuz P, Nurden P, Cid AR, Cuker A, Latger-Cannard V, Favier R, Nichele I, Noris P; European Haematology Association - Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Br J Haematol. 2015 Aug;170(4):559-63. doi: 10.1111/bjh.13458. Epub 2015 Apr 21.

PMID:
25899604
9.

Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.

Larocca LM, Heller PG, Podda G, Pujol-Moix N, Glembotsky AC, Pecci A, Alberelli MA, Balduini CL, Landolfi R, Cattaneo M, De Candia E.

Platelets. 2015;26(8):751-7. doi: 10.3109/09537104.2014.994093. Epub 2015 Mar 25.

PMID:
25806575
10.

Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders.

Noris P, Biino G, Pecci A, Civaschi E, Savoia A, Seri M, Melazzini F, Loffredo G, Russo G, Bozzi V, Notarangelo LD, Gresele P, Heller PG, Pujol-Moix N, Kunishima S, Cattaneo M, Bussel J, De Candia E, Cagioni C, Ramenghi U, Barozzi S, Fabris F, Balduini CL.

Blood. 2014 Aug 7;124(6):e4-e10. doi: 10.1182/blood-2014-03-564328. Epub 2014 Jul 2.

11.

Spectrum of the mutations in Bernard-Soulier syndrome.

Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz H, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, HadjKacem B, Heller PG, Karimi M, Balduini CL, Pastore A, Lanza F.

Hum Mutat. 2014 Sep;35(9):1033-45. doi: 10.1002/humu.22607. Epub 2014 Jul 15. Review.

PMID:
24934643
12.

[The relevance of the ankle-arm index to the reclassification of cardiovascular risk in asymptomatic hypertensive middle-aged males].

Oliveras V, Martín-Baranera M, Gracia M, Del Val JL, Plans M, Pujol-Moix N.

Med Clin (Barc). 2015 May 21;144(10):435-9. doi: 10.1016/j.medcli.2014.02.028. Epub 2014 Jun 2. Spanish.

PMID:
24889750
13.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

14.

MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WH, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia E, Fraticelli V, Kersseboom R, Piccoli GB, Zimmermann S, Fierro T, Glembotsky AC, Vianello F, Zaninetti C, Nicchia E, Güthner C, Baronci C, Seri M, Knight PJ, Balduini CL, Savoia A.

Hum Mutat. 2014 Feb;35(2):236-47. doi: 10.1002/humu.22476. Epub 2013 Dec 12.

15.

Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.

Bottega R, Pecci A, De Candia E, Pujol-Moix N, Heller PG, Noris P, De Rocco D, Podda GM, Glembotsky AC, Cattaneo M, Balduini CL, Savoia A.

Haematologica. 2013 Jun;98(6):868-74. doi: 10.3324/haematol.2012.075861. Epub 2012 Oct 25.

16.

Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study.

García-Dabrio MC, Pujol-Moix N, Martinez-Perez A, Fontcuberta J, Souto JC, Soria JM, Nomdedéu JF.

Acta Haematol. 2012;127(4):244-9. doi: 10.1159/000337051. Epub 2012 Apr 24.

PMID:
22538526
17.

The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia.

Roca M, Muñiz-Diaz E, Mora J, Romero-Zayas I, Ramón O, Roig I, Pujol-Moix N.

Am J Hematol. 2011 Nov;86(11):909-13. doi: 10.1002/ajh.22147. Epub 2011 Sep 21.

18.

Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.

Noris P, Perrotta S, Seri M, Pecci A, Gnan C, Loffredo G, Pujol-Moix N, Zecca M, Scognamiglio F, De Rocco D, Punzo F, Melazzini F, Scianguetta S, Casale M, Marconi C, Pippucci T, Amendola G, Notarangelo LD, Klersy C, Civaschi E, Balduini CL, Savoia A.

Blood. 2011 Jun 16;117(24):6673-80. doi: 10.1182/blood-2011-02-336537. Epub 2011 Apr 5.

PMID:
21467542
19.

Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.

Pippucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G, Pecci A, Gnan C, Punzo F, Marconi C, Gherardi S, Loffredo G, De Rocco D, Scianguetta S, Barozzi S, Magini P, Bozzi V, Dezzani L, Di Stazio M, Ferraro M, Perini G, Seri M, Balduini CL.

Am J Hum Genet. 2011 Jan 7;88(1):115-20. doi: 10.1016/j.ajhg.2010.12.006.

20.

Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder.

Savoia A, De Rocco D, Panza E, Bozzi V, Scandellari R, Loffredo G, Mumford A, Heller PG, Noris P, De Groot MR, Giani M, Freddi P, Scognamiglio F, Riondino S, Pujol-Moix N, Fabris F, Seri M, Balduini CL, Pecci A.

Thromb Haemost. 2010 Apr;103(4):826-32. doi: 10.1160/TH09-08-0593. Epub 2010 Feb 19.

PMID:
20174760
21.

MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype.

Pecci A, Panza E, De Rocco D, Pujol-Moix N, Girotto G, Podda L, Paparo C, Bozzi V, Pastore A, Balduini CL, Seri M, Savoia A.

Eur J Haematol. 2010 Apr;84(4):291-7. doi: 10.1111/j.1600-0609.2009.01398.x. Epub 2009 Dec 11.

PMID:
20002731
22.

Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population.

Vila L, Martinez-Perez A, Camacho M, Buil A, Alcolea S, Pujol-Moix N, Soler M, Antón R, Souto JC, Fontcuberta J, Soria JM.

Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):128-34. doi: 10.1161/ATVBAHA.109.193219. Epub 2009 Oct 22.

23.

Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.

De Rocco D, Pujol-Moix N, Pecci A, Faletra F, Bozzi V, Balduini CL, Savoia A.

Eur J Med Genet. 2009 Jul-Aug;52(4):191-4. doi: 10.1016/j.ejmg.2009.01.006. Epub 2009 Feb 9.

PMID:
19450438
24.

Platelet inorganic polyphosphate decreases in patients with delta storage pool disease.

Hernández-Ruiz L, Sáez-Benito A, Pujol-Moix N, Rodríguez-Martorell J, Ruiz FA.

J Thromb Haemost. 2009 Feb;7(2):361-3. doi: 10.1111/j.1538-7836.2008.03238.x. Epub 2008 Nov 25. No abstract available.

25.

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.

Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, Gresele P, Lethagen S, Fabris F, Dufour C, Granata A, Doubek M, Pecoraro C, Koivisto PA, Heller PG, Iolascon A, Alvisi P, Schwabe D, De Candia E, Rocca B, Russo U, Ramenghi U, Noris P, Seri M, Balduini CL, Savoia A.

Hum Mutat. 2008 Mar;29(3):409-17.

PMID:
18059020
26.

Genotype-phenotype correlation in MYH9-related thrombocytopenia.

Dong F, Li S, Pujol-Moix N, Luban NL, Shin SW, Seo JH, Ruiz-Saez A, Demeter J, Langdon S, Kelley MJ.

Br J Haematol. 2005 Aug;130(4):620-7.

PMID:
16098078
27.

Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders.

Pujol-Moix N, Kelley MJ, Hernández A, Muñiz-Diaz E, Español I.

Haematologica. 2004 Mar;89(3):330-7.

28.

Mutation analysis of HPS1, the gene mutated in Hermansky-Pudlak syndrome, in patients with isolated platelet dense-granule deficiency.

Corral J, González-Conejero R, Pujol-Moix N, Domenech P, Vicente V.

Haematologica. 2004 Mar;89(3):325-9.

29.

Glycoproteins expression on platelet membrane in inherited macrothrombocytopenias.

Pérez-Pujol S, Lozano M, Escolar G, Díaz-Ricart M, Pujol-Moix N, Ordinas A.

Thromb Res. 2003;112(4):233-7.

PMID:
14987917
30.

Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation.

Andreu N, Pujol-Moix N, Martinez-Lostao L, Oset M, Muñiz-Diaz E, Estivill X, Volpini V, Fillat C.

Blood Cells Mol Dis. 2003 Nov-Dec;31(3):332-7.

PMID:
14636648
31.

Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.

Ahnadi CE, Sabrinah Chapman E, Lépine M, Okrongly D, Pujol-Moix N, Hernández A, Boughrassa F, Grant AM.

Thromb Haemost. 2003 Nov;90(5):940-8.

PMID:
14597991
32.

Bone marrow necrosis with Charcot-Leyden crystals in a patient with idiopathic hypereosinophilic syndrome.

Pujol-Moix N, Brunet S, Ayats R.

Haematologica. 2003 Sep;88(9):EIM12. No abstract available.

33.

A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination.

Chapman ES, Sorette M, Hetherington E, Zelmanovic D, Kling G, Dugailliez J, Pujol-Moix N, Okrongly D.

Thromb Haemost. 2003 Jun;89(6):1004-15.

PMID:
12783113
34.
35.

New types of granulocyte inclusions in hereditary macrothrombocytopenias.

Pujol-Moix N, Muñiz-Díaz E, Hernández A, Durfort M.

Platelets. 2002 Nov;13(7):425-6. No abstract available.

PMID:
12487791
36.

Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation.

Remacha AF, Badell I, Pujol-Moix N, Parra J, Muñiz-Diaz E, Ginovart G, Sardà MP, Hernández A, Moliner E, Torrent M.

Blood. 2002 Jul 1;100(1):356-8.

PMID:
12070051
37.

Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.

Arderiu G, Díaz-Ricart M, Domenech P, Escolar G, Ordinas A, Pujol-Moix N.

Haematologica. 2002 Jun;87(6):629-36.

38.

Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin.

Español I, Gallego A, Enríquez J, Rabella N, Lerma E, Hernández A, Pujol-Moix N.

Hepatogastroenterology. 2000 Sep-Oct;47(35):1404-6.

PMID:
11100362
39.
40.

[Thrombopoietin: its discovery and clinical perspectives].

Español I, Pujol-Moix N.

Med Clin (Barc). 2000 Apr 8;114(13):511-6. Review. Spanish. No abstract available.

PMID:
10846658
41.

Adherence of platelets under flow conditions results in specific phosphorylation of proteins at tyrosine residues.

Arderiu G, Estebanell E, Pujol-Moix N, Escolar G, Ordinas A, Díaz-Ricart M.

Cell Adhes Commun. 2000 Jan;7(4):349-58.

PMID:
10714395
42.

Littoral cell angioma with severe thrombocytopenia.

Español I, Lerma E, Fumanal V, Palmer J, Roca M, Domingo-Albós A, Pujol-Moix N.

Ann Hematol. 2000 Jan;79(1):46-9.

PMID:
10663622
43.

[Noonan syndrome with thrombocytopenia secondary to hypersplenism].

Español I, Vendrell T, Mora J, Pujol-Moix N.

Sangre (Barc). 1999 Oct;44(5):387. Spanish. No abstract available.

PMID:
10618918
44.

Serum thrombopoietin levels in thrombocytopenic and non-thrombocytopenic patients with human immunodeficiency virus (HIV-1) infection.

Español I, Muñiz-Diaz E, Margall N, Rabella N, Sambeat MA, Hernández A, Pujol-Moix N.

Eur J Haematol. 1999 Oct;63(4):245-50.

PMID:
10530413
45.

Usefulness of thrombopoietin in the diagnosis of peripheral thrombocytopenias.

Español I, Hernández A, Muñiz-Diaz E, Ayats R, Pujol-Moix N.

Haematologica. 1999 Jul;84(7):608-13.

46.

Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels.

Español I, Hernández A, Cortés M, Mateo J, Pujol-Moix N.

Haematologica. 1999 Apr;84(4):312-6.

47.

Severe immune thrombocytopenia during formestane treatment.

Español I, Muñíz-Díaz E, Alonso MC, Pujol-Moix N.

Haematologica. 1998 Oct;83(10):953-4.

48.

Type IV Ehlers-Danlos syndrome with platelet delta-storage pool disease.

Español I, Hernández A, Pujol RM, Urrutia T, Pujol-Moix N.

Ann Hematol. 1998 Jul-Aug;77(1-2):47-50.

PMID:
9760152
49.

Giant intranuclear granules in human megakaryocytes: an ultrastructural study.

Hernández A, Español I, Pujol-Moix N.

Hum Pathol. 1998 Jul;29(7):756-8.

PMID:
9670835
50.

The magic of immersion oil: gray platelet syndrome.

Español I, Hernández A, Pujol-Moix N.

Haematologica. 1998 May;83(5):474-5. No abstract available.

Supplemental Content

Loading ...
Support Center